9 Meters Biopharma (NMTR) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsInsider TradesSEC FilingsTrendsBuy This Stock NMTR vs. VRAX, IMCC, CNSP, TTNP, RDHL, APVO, MAAQ, NBY, ATNF, and PPBTShould you be buying 9 Meters Biopharma stock or one of its competitors? The main competitors of 9 Meters Biopharma include Virax Biolabs Group (VRAX), IM Cannabis (IMCC), CNS Pharmaceuticals (CNSP), Titan Pharmaceuticals (TTNP), RedHill Biopharma (RDHL), Aptevo Therapeutics (APVO), Mana Capital Acquisition (MAAQ), NovaBay Pharmaceuticals (NBY), 180 Life Sciences (ATNF), and Purple Biotech (PPBT). These companies are all part of the "pharmaceutical products" industry. 9 Meters Biopharma vs. Virax Biolabs Group IM Cannabis CNS Pharmaceuticals Titan Pharmaceuticals RedHill Biopharma Aptevo Therapeutics Mana Capital Acquisition NovaBay Pharmaceuticals 180 Life Sciences Purple Biotech Virax Biolabs Group (NASDAQ:VRAX) and 9 Meters Biopharma (NASDAQ:NMTR) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their risk, media sentiment, community ranking, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations. Is VRAX or NMTR more profitable? Virax Biolabs Group's return on equity of 0.00% beat 9 Meters Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Virax Biolabs GroupN/A N/A N/A 9 Meters Biopharma N/A -584.97%-159.45% Which has more volatility and risk, VRAX or NMTR? Virax Biolabs Group has a beta of 1.61, meaning that its stock price is 61% more volatile than the S&P 500. Comparatively, 9 Meters Biopharma has a beta of 1.36, meaning that its stock price is 36% more volatile than the S&P 500. Do insiders and institutionals hold more shares of VRAX or NMTR? 8.6% of Virax Biolabs Group shares are owned by institutional investors. Comparatively, 22.3% of 9 Meters Biopharma shares are owned by institutional investors. 45.1% of Virax Biolabs Group shares are owned by insiders. Comparatively, 2.4% of 9 Meters Biopharma shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Which has stronger valuation & earnings, VRAX or NMTR? Virax Biolabs Group has higher revenue and earnings than 9 Meters Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVirax Biolabs Group$84.87K44.19-$6.73MN/AN/A9 Meters BiopharmaN/AN/A-$43.77M-$3.46N/A Does the MarketBeat Community believe in VRAX or NMTR? 9 Meters Biopharma received 37 more outperform votes than Virax Biolabs Group when rated by MarketBeat users. CompanyUnderperformOutperformVirax Biolabs GroupN/AN/A9 Meters BiopharmaOutperform Votes3771.15% Underperform Votes1528.85% Does the media refer more to VRAX or NMTR? In the previous week, Virax Biolabs Group had 2 more articles in the media than 9 Meters Biopharma. MarketBeat recorded 2 mentions for Virax Biolabs Group and 0 mentions for 9 Meters Biopharma. Virax Biolabs Group's average media sentiment score of 1.44 beat 9 Meters Biopharma's score of 0.00 indicating that Virax Biolabs Group is being referred to more favorably in the media. Company Overall Sentiment Virax Biolabs Group Positive 9 Meters Biopharma Neutral SummaryVirax Biolabs Group beats 9 Meters Biopharma on 8 of the 10 factors compared between the two stocks. Remove Ads Get 9 Meters Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTR vs. The Competition Export to ExcelMetric9 Meters BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.04M$110.43M$5.63B$7.84BDividend YieldN/A3.78%5.33%4.01%P/E Ratio-0.023.1423.6018.74Price / SalesN/A4,278.81388.2490.77Price / CashN/A12.7538.1734.64Price / BookN/A36.766.894.23Net Income-$43.77M-$91.48M$3.20B$247.47M 9 Meters Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTR9 Meters BiopharmaN/AN/AN/AN/A$1.04MN/A-0.0220VRAXVirax Biolabs Group1.6629 of 5 stars$1.28+4.9%N/A+61.8%$4.14M$84,872.000.005Short Interest ↓Gap UpIMCCIM Cannabis1.3958 of 5 stars$1.79flatN/A-42.1%$4.00M$51.39M-0.53340Upcoming EarningsShort Interest ↓News CoverageCNSPCNS Pharmaceuticals1.8497 of 5 stars$3.38-8.9%$25.00+639.6%-99.9%$3.89MN/A-0.055Analyst ForecastShort Interest ↓Gap UpTTNPTitan Pharmaceuticals1.5694 of 5 stars$4.14-1.2%N/A-48.6%$3.78M$180,000.00-0.7910Upcoming EarningsAnalyst ForecastShort Interest ↓Gap UpRDHLRedHill Biopharma0.482 of 5 stars$2.94-1.8%N/A-99.2%$3.76M$3.71M0.00210Analyst ForecastShort Interest ↑Gap DownAPVOAptevo Therapeutics2.1466 of 5 stars$2.32-9.7%$10,952.00+471,969.0%-100.0%$3.75M$3.11M0.0050Short Interest ↑Gap DownMAAQMana Capital AcquisitionN/A$0.45+2.3%N/A-73.3%$3.66MN/A0.001High Trading VolumeNBYNovaBay Pharmaceuticals1.5293 of 5 stars$0.62-4.3%$0.85+37.1%-83.4%$3.61M$13.84M-0.0130Analyst ForecastATNF180 Life SciencesN/A$1.11-1.8%N/A-55.8%$3.59MN/A0.007Short Interest ↑News CoveragePPBTPurple Biotech2.0789 of 5 stars$2.69-1.5%$33.00+1,126.8%N/A$3.58MN/A-0.3120 Remove Ads Related Companies and Tools Related Companies VRAX Alternatives IMCC Alternatives CNSP Alternatives TTNP Alternatives RDHL Alternatives APVO Alternatives MAAQ Alternatives NBY Alternatives ATNF Alternatives PPBT Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTR) was last updated on 3/30/2025 by MarketBeat.com Staff From Our PartnersTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | SponsoredThe Dirty Secret About Gold Mining Stocks...Here's something most gold analysts won't tell you: 90% of gold mining companies actually destroy sharehold...Golden Portfolio | SponsoredNvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...Brownstone Research | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredYour Wealth is Under AttackPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredWall Street’s “AI Oracle” Reveals Next Big Tech PlayA tiny American tech company could be at the center of the next big AI breakthrough. Wall Street's "AI Orac...InvestorPlace | SponsoredElon’s ‘Strike Squad’ sends these 9 stocks soaring?Elon Musk's DOGE 'strike squad' just revealed it's speeding up the rollout of a radical technology across the ...Altimetry | SponsoredDoomed: These 50 Stocks Will Die Under Trump’s MAGA policies.Remember Kodak? Sears? Circuit City? They all failed to adapt to the changing times. Now, history is abo...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 9 Meters Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 9 Meters Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NMTR Stock Free NMTR Stock Alerts